U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556718) titled 'Amitriptyline for IBS-like Symptoms in Quiescent Crohn's Disease' on April 22.
Brief Summary: Many individuals with Crohn's disease continue to experience abdominal pain, bloating, or bowel habit changes even when their inflammation is controlled. Amitriptyline is a medication commonly used at low doses to treat irritable bowel syndrome (IBS) and abdominal pain. This study will assess whether amitriptyline is safe and reduces those ongoing GI symptoms in adults with Crohn's disease in remission.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Quiescent Crohn's Disease (CD)
Intervention:
DRUG: Amitriptyline...